GlassScriptPhysician profile
Derrick M Dillow
NPI 1548924590
$2,552.04
in general payments reported to CMS, 2019-2025
36 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.75 · 2022: $302 · 2023: $764 · 2024: $360 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,237.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $392.47 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $298.41 | 2023-2025 | |
| Lilly USA, LLC | $229.43 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Abbvie INC. | $195.91 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $158.22 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $127.79 | 2022-2025 | Evenity, Prolia, Repatha |
| Dexcom, INC. | $109.86 | 2023-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $104.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $96.13 | 2022-2023 | Spravato |
| Glaxosmithkline, LLC. | $84.46 | 2023-2025 | Shingrix, Bexsero, Arexvy |
| Astellas Pharma US INC | $70.31 | 2024-2025 | Veozah |
| Gilead Sciences, INC. | $63.34 | 2022-2023 | |
| Axsome Therapeutics, INC. | $60.13 | 2023-2025 | Auvelity |
| Sanofi-Aventis U.S. LLC | $49.41 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $43.02 | 2025 | Rexulti |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.01 | 2024-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $34.73 | 2021-2025 | Trintellix |
| Qol Medical, LLC | $33.54 | 2023 | Sucraid |
| Merck Sharp & Dohme LLC | $32.84 | 2022-2024 | M-M-R II, Capvaxive, Gardasil 9 |
| Viiv Healthcare Company | $31.42 | 2023 | Apretude |
| Phadia US INC. | $30.41 | 2022-2023 | Immunocap |
| Insulet Corporation | $29.60 | 2025 | Omnipod |
| Ironshore Pharmaceuticals INC. | $24.04 | 2024 | |
| Abbott Laboratories | $23.45 | 2024 | Freestyle Libre 3 |
| Teleflex LLC | $18.91 | 2023 | Urolift |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.30 | 2024 | Caplyta |
| Inspire Medical Systems, INC. | $17.29 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $17.02 | 2025 | |
| Medtronic, INC. | $16.98 | 2025 | Intellis Adaptivestim |
| Phathom Pharmaceuticals, INC. | $16.16 | 2025 | Voquezna |
| Cranial Technologies, INC | $16.10 | 2023 | Doc Band |
| Dynavax Technologies Corporation | $15.66 | 2022 | |
| Philips North America LLC | $14.71 | 2022 | |
| Tactile Systems Technology INC | $14.15 | 2024 | Flexitouch Plus, Entre Plus |
| Inari Medical, INC. | $13.46 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Idorsia Pharmaceuticals US INC | $12.75 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Dillow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.